Sunday, October 25, 2009

Digital Journalist Offers Balanced Treatment of H1N1 Vaccine Safety

In H1N1 vaccine safety becomes an issue in Canada Stephanie Dearing, a digital journalist writing on the Digital Journal web site has, unlike most mainstream media vaccine cheerleaders, produced some balanced coverage of H1N1 vaccine safety issues in Canada. In particular, Ms Dearing points out that Canada, unlike many jurisdictions, including the US, is going bold with adjuvant boosted vaccines.

Amongst the interesting pieces of information found in the article is the State of California labelling requirement for thimerosal which will be contained in the Canadian purchased vaccines:

"The State of California has required products containing harmful metals, or chemicals be labelled with a warning
"This product contains the following ingredients for which the State of California has found to cause cancer, birth defects or other reproductive harm, which would require a warning under the statute: Thimerosal.""
The mainstream media has long ago abandoned any realistic pretence of objectivity on vaccine issues. It is no wonder that the aggressive public health campaign against those with questions about vaccine safety or efficacy has branded internet sources as inherently untrustworthy (unless they support vaccine programs). Ms Dearing's effort adds some much needed balance to a discussion that vaccine promoters are trying desperately to extinguish.

Bookmark and Share

1 comment:

CK said...

I wouldn't get the vaccine:

The fact that neither the pharma company who sold the vaccine to Canadian Gov't nor the gov't itself is willing to implement a compensation program for those injured from the vaccine speaks volumes to me. It means they don't stand behind their product.

Only Quebec, to my knowledge has a no fault compensation program.